Relmada Therapeutics Inc (RLMD)
3.83
+0.13
(+3.51%)
USD |
NASDAQ |
Apr 26, 16:00
3.835
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics Net Income (TTM): -98.79M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -98.79M |
| September 30, 2023 | -111.57M |
| June 30, 2023 | -128.99M |
| March 31, 2023 | -143.62M |
| December 31, 2022 | -157.04M |
| September 30, 2022 | -153.48M |
| June 30, 2022 | -156.67M |
| March 31, 2022 | -143.28M |
| December 31, 2021 | -125.75M |
| September 30, 2021 | -112.14M |
| June 30, 2021 | -86.43M |
| March 31, 2021 | -71.00M |
| December 31, 2020 | -59.46M |
| September 30, 2020 | -42.36M |
| June 30, 2020 | -29.58M |
| March 31, 2020 | -21.15M |
| September 30, 2019 | -17.61M |
| June 30, 2019 | -17.32M |
| March 31, 2019 | -16.55M |
| December 31, 2018 | -17.06M |
| September 30, 2018 | -11.36M |
| June 30, 2018 | -8.961M |
| Date | Value |
|---|---|
| March 31, 2018 | -7.244M |
| December 31, 2017 | -6.024M |
| September 30, 2017 | -5.628M |
| June 30, 2017 | -6.286M |
| March 31, 2017 | -7.970M |
| December 31, 2016 | -7.849M |
| September 30, 2016 | -9.278M |
| June 30, 2016 | -2.975M |
| March 31, 2016 | 6.385M |
| December 31, 2015 | 5.782M |
| September 30, 2015 | 13.70M |
| June 30, 2015 | -20.80M |
| March 31, 2015 | -26.85M |
| December 31, 2014 | -24.40M |
| September 30, 2014 | -29.87M |
| February 28, 2014 | -0.0493M |
| November 30, 2013 | -0.0504M |
| August 31, 2013 | -0.045M |
| May 31, 2013 | -0.0413M |
| February 28, 2013 | -0.0243M |
| November 30, 2012 | -0.0206M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-157.04M
Minimum
Dec 2022
-17.32M
Maximum
Jun 2019
-93.12M
Average
-105.18M
Median
Net Income (TTM) Benchmarks
| Cyclacel Pharmaceuticals Inc | -22.56M |
| Lifecore Biomedical Inc | -100.12M |
| Corvus Pharmaceuticals Inc | -27.03M |
| NeuroBo Pharmaceuticals Inc | -12.47M |
| Ensysce Biosciences Inc | -10.63M |